REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Noripharma Sdn. Bhd. (Malaysia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Noripharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Noripharma Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Klang. It operates in the Medicinal and Botanical Manufacturing sector. It was established on October 23, 2007. In 2022, the company reported a net sales revenue increase of 21.04%. Its’ total assets recorded a growth of 25.62%. Noripharma Sdn. Bhd.’s net profit margin increased by 4.37% in 2022.

Headquarters
Lot 5030, Jalan Teratai 5 1/2 Miles, Off Jalan Meru
Klang; Selangor; Postal Code: 41050

Contact Details: Purchase the Noripharma Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the Noripharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Noripharma Sdn. Bhd. report to view the information.
Incorporation Date:
October 23, 2007
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Subsidiaries
Scynergy Research Sdn. Bhd.
50%
Company Performance
Financial values in the chart are available after Noripharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
21.04%▲
Total Operating Revenue
21.04%▲
Operating Profit
41.86%▲
EBITDA
32.03%▲
Net Profit/Loss for the Period
44.12%▲
Total Assets
25.62%▲
Total Equity
27.29%▲
Operating Profit Margin
5.07%▲
Net Profit Margin
4.37%▲
Return on Equity (ROE)
2.54%▲
Quick Ratio
0.72%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo